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Background: One of the challenges facing the fuel ethanol industry is the management of bacterial contamination
during fermentation. Lactobacillus species are the predominant contaminants that decrease the profitability of
biofuel production by reducing ethanol yields and causing “stuck” fermentations, which incur additional economic
losses via expensive antibiotic treatments and disinfection costs. The current use of antibiotic treatments has led to
the emergence of drug-resistant bacterial strains, and antibiotic residues in distillers dried grains with solubles (DDGS)
are a concern for the feed and food industries. This underscores the need for new, non-antibiotic, eco-friendly
mitigation strategies for bacterial contamination. The specific objectives of this work were to (1) express genes
encoding bacteriophage lytic enzymes (endolysins) in Saccharomyces cerevisiae, (2) assess the lytic activity of the
yeast-expressed enzymes against different species of Lactobacillus that commonly contaminate fuel ethanol
fermentations, and (3) test the ability of yeast expressing lytic enzymes to reduce Lactobacillus fermentum during
fermentation. Implementing antibiotic-free strategies to reduce fermentation contaminants will enable more
cost-effective fuel ethanol production and will impact both producers and consumers in the farm-to-fork continuum.
Results: Two genes encoding the lytic enzymes LysA and LysA2 were individually expressed in S. cerevisiae on
multi-copy plasmids under the control of a galactose-inducible promoter. The enzymes purified from yeast were
lytic against Lactobacillus isolates collected from fermentors at a commercial dry grind ethanol facility including
Lactobacillus fermentum, Lactobacillus brevis, and Lactobacillus mucosae. Reductions of L. fermentum in experimentally
infected fermentations with yeast expressing LysA or LysA2 ranged from 0.5 log10 colony-forming units per mL
(CFU/mL) to 1.8 log10 (CFU/mL) over 72 h and fermentations treated with transformed yeast lysate showed reductions
that ranged from 0.9 log10 (CFU/mL) to 3.3 log10 (CFU/mL). Likewise, lactic acid and acetic acid levels were reduced in
all experimentally infected fermentations containing transformed yeast (harboring endolysin expressing plasmids)
relative to the corresponding fermentations with untransformed yeast.
Conclusions: This study demonstrates the feasibility of using yeast expressing bacteriophage endolysins to reduce
L. fermentum contamination during fuel ethanol fermentations.
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The primary feedstock for fuel ethanol production in the
United States is glucose from corn starch [1], with
annual production at roughly 13 billion gallons in 2012
[2]. Strategies to meet future production demands include
developing genotypes of corn that yield a higher starch
content, increasing land area designated for corn produc-
tion, and utilizing alternative feedstocks to supplement
corn-based fuel ethanol. Lignocellulosic biomass is a prom-
ising alternative renewable carbon source; however, the
technology is still evolving and is constrained by production
costs [3]. Therefore, in addition to research on commer-
cializing lignocellulose to fermentable sugars, methods
to improve the efficiency of ethanol production from
starch-based feedstocks must continue.
Fuel ethanol production is not performed under aseptic
conditions, and the economics of fuel ethanol production
are threatened by Gram-positive and Gram-negative bac-
teria that contaminate commercial fuel ethanol plants and
reduce ethanol yields [4-7]. Lactic acid bacteria (LAB)
are the primary bacterial contaminants of fuel ethanol
fermentations with species of Lactobacillus predominating.
Chronic LAB contamination reduces available glucose for
conversion to ethanol and reduces essential micronutrients
required for optimal yeast growth, resulting in reduced
ethanol yields. Acute infections are unpredictable and are
characterized by the accumulation of bacterial by-products
such as lactic acid and acetic acid. These organic acids
inhibit yeast growth [8-15] and may cause stuck fermen-
tations (incomplete conversion of glucose to ethanol)
that require costly shutdowns of facilities for cleaning
and disinfecting [4,7,9,16]. Lactobacilli flourish in the
glucose-rich fermentation environment and are well
adapted for survival under the high ethanol, low pH,
and low oxygen conditions present during fermentation
[6,17,18]. For example, Lactobacillus fermentum infection
of Saccharomyces cerevisiae fermentations can reduce
ethanol yields by up to 27% [4].
Contamination may occur at different locations within
the fuel ethanol production pipeline. Previous work
showed that lactobacilli are found at locations after the
heat exchanger (unpublished data). Samples taken from
strategic points along the production line demonstrated
that saccharification tanks, continuous yeast propagation
systems, and biofilms may act as reservoirs of bacteria that
continually reintroduce contaminants [6,19]. There are
numerous strategies to control contamination, including
the use of chemical treatments, natural compounds, plant-
derived compounds, and antibiotics (reviewed in [20]). Each
of these control strategies varies in effectiveness and
burdens fuel ethanol facilities with additional costs
[20-24]. Antibiotics are the most common strategy used
to control contamination in fuel ethanol facilities [5,25].
Penicillin and virginiamycin [26,27] are frequently appliedto fermentations to control bacterial contamination, which
has resulted in the emergence of multidrug-resistant
isolates [17,25], limiting their effectiveness. Thirty-eight
percent of Lactobacillus isolates from a dry grind ethanol
plant that routinely used virginiamycin were found to har-
bor the vat(E) gene, whose product inactivates virginiamy-
cin by acetylation of its hydroxyl group [28].
Bacteriophage endolysins are lytic enzymes that offer a
novel approach to reduce bacterial contamination in fuel
ethanol facilities and avoid the resistance pitfalls that are
often associated with antibiotics and other antimicrobials
(such as hop acids [29]). Endolysins have co-evolved with
their host strains to degrade the peptidoglycan (PG) cell
wall [30-32]. Once the cell wall has been compromised,
the high internal pressure of bacterial cells causes osmoly-
sis (lysis from within), enabling the release of phage pro-
geny at the end of the phage lytic replication cycle [33].
Gram-positive bacteria, which have a thick PG cell wall
(up to 40 layers thick) and no outer membrane, can also
lyse Gram-positive bacteria when exposed externally to
purified endolysins (lysis from without) [30-32]. In con-
trast, the cell walls of Gram-negative bacteria harbor an
outer membrane that blocks access of most endolysins to
the PG located in the periplasmic space. PG is unique to
bacteria and exists as a complex polymer structure [34] of
alternating units of N-acetyl glucosamine and N-acetyl-
muramic acid, which are cross-linked by oligopeptide
chains attached to muramic acid residues [35]. Endolysins
have a modular structure, usually composed of N-terminal
catalytic domain(s) (that is, endopeptidase, glycosidase,
and amidases) and a C-terminal cell wall binding domain
(CBD) [36,37]. Endolysins show near-species specificity
and are highly refractory to resistance development [30-32],
likely due to their co-evolution with their host, and because
of the need to target highly immutable PG structures in
order to ensure phage escape from the host cell and the
clade survival. Further decreasing the risk of resistance
development to endolysins is the localization of the
Gram-positive PG layer outside the cytoplasmic mem-
brane, since most antibiotic resistance mechanisms act
on compounds that localize intracellularly (for example,
efflux pumps; see [38] for a review). There have been no
reports to date of extracellular inactivation of PG hy-
drolases (endolysins).
Applying purified endolysins may be prohibitively expen-
sive for large-scale commercial fermentations. To address
this issue in the brewing and wine-making industries, it has
been proposed that genetic engineering can improve micro-
bial catalysts to resist contamination [39,40]. Previous work
has demonstrated brewer’s yeast bred to contain anti-
contaminant properties [41]. Schoeman et al. [42] con-
structed a bactericidal yeast strain expressing and secreting
the Pediococcus acidilactici pediocin, an antibacterial pep-
tide with specificity for Listeria and Leuconostoc species.
Figure 1 Schematic of yeast expression vector. High copy yeast
expression vector used to transform yeast strain BY4727 for corn
mash fermentation assays, containing the URA3 selectable marker
and either LysA or LysA2, which were expressed under the
regulation of the Gal1 promoter.
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recombinant endolysins (LysA, LysA2, LysgaY, and λSa2)
that were purified from Escherichia coli to lyse a variety of
lactobacilli under different pH values and ethanol concen-
trations. In this study, we demonstrate that S. cerevisiae
expressing either of two phage lytic enzymes (LysA or
LysA2) reduces the concentration of L. fermentum in ex-
perimentally infected corn mash fermentations.
Methods
Strains and plasmids
Saccharomyces cerevisiae strain BY4727 (hisΔ200 leuΔ0
lys2Δ0 met15Δ0 trp1Δ63 ura3Δ0) [44] was kindly provided
by Dr. Ron Hector and used for all yeast experiments de-
scribed in this work. The media used for culturing BY4727
was similar to that described previously [45]. All yeast
transformations were conducted following Invitrogen’s
small-scale transformation protocol. Untransformed yeasts
were grown in yeast extract peptone dextrose (YPD)
medium (1% yeast extract, 2% peptone, and 2% dextrose),
and transformed yeasts were grown on synthetic drop-out
medium containing yeast nitrogen base without amino
acids (0.67%), 2% glucose, and supplemented with amino
acids. The drop-out medium without uracil (SD-ura) con-
tained all standard amino acids (76 mg/L final) and lacked
uracil (Sigma, St. Louis, MO). The induction medium was
similar to the SD-ura medium except that glucose was
replaced with galactose (final concentration 2%). Glucose
and galactose were filter sterilized using Nalgene Rapid-
Flow sterile disposable bottle top polyethersulfone (PES)
membrane filters (Fisher Scientific, Pittsburgh, PA).
L. fermentum 0605-B44, Lactobacillus brevis 0605-48,
and Lactobacillus mucosae 0713-2 were isolated from
fermentors at commercial dry grind ethanol facilities lo-
cated within the Midwestern United States [4]. Lactobacilli
were grown to mid-log phase (OD600 nm = 0.4-0.6) at 37°C
without shaking in de Man, Rogosa and Sharpe (MRS)
broth. The optical densities at 600 nm (OD600 nm) of
the overnight bacterial cultures were measured using the
SmartSpec Plus spectrophotometer (Bio-Rad, Hercules,
CA).
The His6-tagged recombinant endolysin genes encoding
LysA and LysA2 were yeast codon optimized, commercially
synthesized, and cloned into the pUC57 vector (GenScript,
Piscataway, NJ). Endolysin genes were then PCR amplified
using the high-fidelity Easy-A polymerase (Stratagene, La
Jolla, CA). The PCR-amplified endolysin genes were TOPO
cloned into Invitrogen’s high copy yeast expression vector
pYES2.1 (Invitrogen, Carlsbad, CA) using standard molecu-
lar techniques. Endolysin expression was under the control
of the Gal1 galactose-inducible promoter. A schematic
of the vector harboring the endolysin that was transformed
into BY4727 (Figure 1) was created using SeqBuilder
(Lasergene version 10.0.0; DNASTAR, Madison, WI, USA).Vector-gene combinations were first transformed into
TOP10 chemically competent E. coli cells by following
Invitrogen’s One Shot TOP10 chemical transformation
protocol.
Yeast expression and purification of endolysins
The liquid SD-ura medium was inoculated with transformed
yeast cells from an SD-ura medium 2% agar plate and grown
at 30 ºC overnight. The OD600 nm of the overnight yeast
culture was measured using the SmartSpec Plus spec-
trophotometer. Cells were isolated via centrifugation
and resuspended in 1 L of induction medium (in a 2-L
flask) to an OD600 nm equivalent to 0.4. Induced cultures
were incubated at 30°C with shaking at 200 RPM for
24 h. Cells were harvested by centrifugation for 5 min at
1,500 × g and resuspended in 10 mL of lysis buffer
(50 mM NaH2PO4, 300 mM NaCl, 0.1% polyethylenimine
(PEI), 30% glycerol, pH 8.0) and homogenized via an
EmulsiFlex-CF homogenizer (Avestin, Ottawa, Ontario,
Canada) at 25,000 psi for 20 min. Lysate was centrifuged
(15,000 RPM for 30 min) in a Thermo Scientific Sorvall
RC 6+ centrifuge (Thermo Scientific, Waltham, MA), and
the His6-tagged proteins were purified from the clarified
supernatant by metal ion affinity chromatography using
Ni-NTA resin (Qiagen, Valencia, CA). Endolysins were
purified as previously described (Roach et al. [43]) using
40 column volumes (CV) of lysis buffer and 15 CV of
wash buffer (50 mM NaH2PO4, 300 mM NaCl, 20 mM
imidazole, 30% glycerol, pH 8.0), and proteins were eluted
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250 mM imidazole, 30% glycerol, pH 8.0). The concentra-
tion of purified proteins was determined at OD280 nm
using a NanoDrop ND-1000 (NanoDrop Technologies,
Wilmington, DE), and the purity was verified via sodium
dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-
PAGE). The SDS-PAGE gels were stained with LabSafe
GEL Blue (G-Biosciences, St. Louis, MO).
Zymogram and turbidity reduction analysis
Zymogram and turbidity reduction assays were conducted
as described previously with minor modifications [43]. For
the zymogram experiments, L. fermentum 0605-B44 cells
were grown to mid-log phase in 350 mL MRS media,
pelleted at 12,000 RPM for 5 min, washed with 10 mL of
zymogram buffer (10 mM Tris, 150 mM NaCl, pH 7.5),
and pelleted. Cells were resuspended in 300 μL of zymo-
gram buffer, which led to a final volume of approximately
600 μL cells in buffer. The purified proteins and Precision
Plus Protein All Blue standard (Bio-Rad) were analyzed in
parallel in two 15% SDS-PAGE gels, one that contained
600 μL of L. fermentum cells (zymogram) and one that
contained 600 μL of buffer only (in place of cells), each of
which was added prior to gel polymerization. Gels were
electrophoresed at 150 V until completion (1.0-1.5 h).
SDS-PAGE gels were stained with LabSafe GEL Blue, and
zymograms were washed in deionized (DI) water for 1 h
at room temperature. After 1 h, zymograms were incu-
bated in 50 mM Tris-HCl, 1% Triton X-114, pH 5.5 at
room temperature overnight or until visible translucent
bands appeared (at approximately 18 h).
Turbidity reduction assays were performed in a Bench-
mark Plus microplate spectrophotometer (Bio-Rad) with
yeast-expressed proteins purified as described above and
E.coli-expressed proteins purified as described previously
[43]. L. fermentum, L. brevis, and L. mucosae were grown
to mid-log phase in 350 mL MRS broth, pelleted, washed
in 10 mL buffer (phosphate buffered saline (PBS; Fisher
Scientific), pH 7.4, 30% glycerol), and frozen overnight
at -20°C. Cell pellets were thawed on ice and resuspended
to OD600 nm = 2.0 in PBS, pH 5.5 to a final volume of
200 μL. Each designated experimental well of a 96-well
plate contained 1 μM endolysin and 100 μL of cell suspen-
sion. Control samples containing just endolysin storage
buffer (50 mM NaH2PO4, 300 mM NaCl, 250 mM
imidazole, 30% glycerol, pH 8.0), without endolysin,
were included in every run. Immediately, absorbance
milli-OD600 nm (mOD600 nm) readings were taken every
30 s for 30 min and specific activities were determined
(ΔmOD600 nm/min/μM) on a sliding scale as described
by Becker et al. [46]. To control for the effect of au-
tolysis, the rates of the control samples (cells alone)
were subtracted from the rates of the experimental
samples.Preparation of yeast cultures and Lactobacillus fermentum
inoculum for fermentations
Both untransformed and transformed yeast strains
BY4727 were grown for 24 h at 30°C with shaking (200
RPM) in 100 mL of YPD media and SD-ura media, respect-
ively. Cells of untransformed yeast and transformed yeast
were then isolated by centrifugation at 1,500 × g for 5 min.
The supernatants were discarded, and the cell pellets were
resuspended in a volume of either 25% galactose or DI
water to obtain an OD600 nm equivalent to 160. A 1-mL
aliquot was then used to inoculate the fermentations
(described below) to obtain a final OD600 nm equivalent
to 8.0.
For the experimentally infected fermentations, stock
cultures of L. fermentum 0605-B44 were grown in 50-mL
static cultures of MRS media at 37°C to mid-log phase
(OD600 nm = 0.4-0.6). Cells were harvested by centrifuga-
tion at 8,000 RPM for 5 min and resuspended in a volume
of phosphate buffered saline, pH 7.4 (PBS; Fisher Scien-
tific), which was necessary to obtain a concentration of 9
log10 (CFU/mL) (OD600 nm = 1.0 is approximately 8.7 log10
(CFU/mL)). Cells were then diluted by transferring 100 μL
of cells at 9 log10 (CFU/mL) to 10 mL of PBS to obtain a
cell density of 7 log10 (CFU/mL).
Preparation and fermentation of corn mash
Corn mash (about 33% solids) was obtained from a
commercial dry grind ethanol facility and stored at -20°C
as described previously [4]. For each 20-mL shake-flask
fermentation, corn mash solids were diluted to 20%
solids by addition of the following components to 25-mL
Erlenmeyer flasks: 12.0 mL corn mash, 6.8 mL 25% galact-
ose (induced fermentations) or DI water (non-induced
fermentations), 1.0 mL of transformed yeast resuspended
in 25% galactose or untransformed yeast resuspended
in 1.0 mL DI water, 0.2 mL 12% (NH4)2SO2, and 10 μL
glucoamylase (Optidex L-400; Genencor International
Inc., Rochester, NY). For induced fermentations, the
final concentration of galactose was 10% as described
previously [47].
Each fermentation flask was inoculated with either un-
transformed yeast or transformed yeast (containing LysA
or LysA2) (Table 1), plugged with a rubber stopper con-
taining a 0.9 mm× 40 mm PrecisionGlide Needle (Becton
Dickinson, East Rutherford, NJ) to allow for CO2 escape,
and placed in a shaking incubator set at a speed of 100
RPM and a temperature of 35°C for 3 h to acclimate the
yeast. All fermentation flasks were then removed from the
incubator. Fermentations that were designated to be
experimentally infected were inoculated with 200 μL of
7 log10 (CFU/mL) L. fermentum cells to obtain a final
density of 5 log10 (CFU/mL). Following infection, all
fermentation flasks were returned to an incubator with
shaking at 32°C and 100 RPM to begin the experiment
Table 1 Lactic acid, acetic acid, and ethanol concentrations over 72 h from experimentally infected fermentations
Treatment and yeast variant1 N Lactic acid2 Acetic acid2 Ethanol2
(mg/mL ± SEM) (mg/mL ± SEM) (mg/mL ± SEM)
0 h 24 h 48 h 72 h 0 h 24 h 48 h 72 h 0 h 24 h 48 h 72 h
Induced LysA 4 0.1a ± 0.0 0.4b ± 0.2 1.9b ± 0.7 2.7bc ± 1.0 0.2a ± 0.0 1.0bc ± 0.2 2.1cd ± 0.4 2.8bc ± 0.6 2.8a ± 0.8 22.0a ± 3.5 36.5a ± 2.6 45.4a ± 2.7
LysA2 4 0.1a ± 0.0 0.1b ± 0.0 0.5c ± 0.3 1.7cd ± 0.6 0.1a ± 0.0 0.6c ± 0.1 1.4de ± 0.2 1.9cd ± 0.4 2.6a ± 0.6 18.0a ± 4.4 35.7a ± 6.6 41.2ab ± 7.9
Untransformed 4 0.1a ± 0.0 0.9b ± 0.5 2.7b ± 0.4 3.4b ± 0.5 0.1a ± 0.0 1.3b ± 0.3 2.5bc ±0.3 3.0b ± 0.3 3.0a ± 0.4 23.6a ± 3.3 36.9a ± 5.1 41.5ab ± 6.6
Induced and yeast
lysate-treated (BB)
LysA 4 0.1a ± 0.0 0.1b ± 0.0 0.1c ± 0.0 0.1d ± 0.0 0.1a ± 0.0 0.8bc ± 0.2 1.1e ± 0.2 1.3de ± 0.3 3.3a ± 0.7 22.3a ± 3.8 36.9a ± 5.2 46.2a ± 7.0
LysA2 4 0.1a ± 0.0 0.1b ± 0.0 0.1c ± 0.0 0.1d ± 0.0 0.1a ± 0.0 0.7bc ± 0.1 0.9e ± 0.2 1.0e ± 0.2 2.9a ± 0.8 20.2a ± 4.6 29.9ab ± 5.2 34.1ab ± 5.3
Untransformed 3 0.1a ± 0.0 0.3b ± 0.2 2.1b ± 0.2 3.7b ± 0.6 0.1a ± 0.0 0.9bc ± 0.1 2.1cd ± 0.2 2.9bc ± 0.1 2.4a ± 0.5 17.1a ± 2.8 29.4ab ± 4.3 37.4ab ± 6.0
Non-induced LysA 3 0.1a ± 0.0 3.3a ± 0.7 4.8a ± 0.8 6.5a ± 0.8 0.1a ± 0.0 2.1a ± 0.4 3.2ab ± 0.4 4.3a ± 0.4 2.5a ± 1.0 15.4a ± 2.4 21.0b ± 2.8 24.5b ± 2.7
LysA2 3 0.1a ± 0.0 3.1a ± 0.5 5.5a ± 0.6 6.4a ± 0.8 0.1a ± 0.0 2.2a ± 0.1 3.7a ± 0.1 4.4a ± 0.2 2.3a ± 0.2 19.3a ± 2.1 30.2ab ± 3.5 33.4ab ± 4.1
Untransformed 4 0.1a ± 0.0 2.9a ± 0.2 4.4a ± 0.6 6.1a ± 0.6 0.2a ± 0.1 2.0a ± 0.1 3.0ab ± 0.2 4.1a ± 0.3 2.8a ± 0.3 24.0a ± 1.2 31.5ab ± 0.7 35.6ab ± 2.7
1Fermentations were conducted using S. cerevisiae strain BY4727. Induced fermentations contained 10% galactose, while non-induced fermentations were supplemented with deionized water. Experimentally infected
fermentations were inoculated at time zero with 5 log10 (CFU/mL) L. fermentum 0605-B44. To prepare a yeast lysate containing LysA or LysA2, 10% of the fermentation volume was removed at 0 h and 0.5 h and was
mechanically lysed (bead beating; BB) for five rounds of 30 s followed by 30 s on ice and returned to the fermentation.
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0, 0.5, 1.0, 1.5, 24, 48, and 72 h and diluted 1:10 in PBS,
pH 7.4 for bacterial CFU determination (serial dilution
plating as described below) and quantification of glucose,
galactose, lactic acid, and acetic acid using high per-
formance liquid chromatography (HPLC) as described
by Bischoff et al. [4]. For fermentations designated to be
treated with mechanically lysed yeast (bead beating;
BB), immediately following sample removal at 0 h and
0.5 h, 2 mL of the fermentation mixture was removed
and subjected to five rounds of 30-s BB followed by 30 s
on ice and returned to the fermentation. BB was per-
formed at a 1:1 ratio of glass beads to corn mash using
acid-washed glass beads (425-600 μm) (Sigma, St. Louis,
MO) in a Mini-Beadbeater (BioSpec products, Bartlesville,
OK).
Fermentation samples were titered for bacterial content
by serial dilution plating on 1.5% MRS agar containing
100 μg/mL cyclohexamide (yeast inhibitor) and incubated
anaerobically using the AnaeroPack System (Mitsubishi,
Tokyo, Japan) at 37°C for 18 h. Plating was conducted
using the Eddy Jet 2 spiral plater (IUL Instruments,
Barcelona Spain) set in E mode 50, which dispenses a
50-μL sample. Colonies were counted and cell concentra-
tions determined (CFU/mL) using the Flash & Go plate
reader (IUL Instruments, Barcelona, Spain). A count of
ten colonies or more was considered acceptable, and thus
our minimum detection limit was determined to be 3.3
log10 (CFU/mL).
Western blot analysis
Protein extraction for the corn mash samples was con-
ducted based on the method of Kushnirov [48] for
western blot analysis. A fermentation sample of 250 μl
was centrifuged at 1,500 × g for 5 min. The supernatant
was removed, and the mash pellet was resuspended in
a mixture of 250 μL DI water and 250 μL of 0.2 M
NaOH, and held at room temperature for 5 min. Fol-
lowing incubation, the sample was centrifuged, resus-
pended in 250 μL of SDS sample buffer, and boiled for
3 min. The boiled sample was pelleted in an Eppendorf
centrifuge 5415D (Eppendorf, Hamburg, Germany) at
full speed for 2 min, and 15 μL of sample buffer was
loaded onto a stain-free 12% precast polyacrylamide
gel (Bio-Rad) and electrophoresed at 150 V for about
1 h. After electrophoresis, protein was transferred to a
nitrocellulose membrane (Bio-Rad) in a semi-dry transfer
chamber at 25 V for 20 min at room temperature. The
transfer buffer was composed of 25 mM Tris, 192 mM
glycine, and 20% HPLC grade methanol. The membrane
was blocked in 0.5% alkali-soluble casein in Tris-buffered
saline with Tween 20 (TBST; 10 mM Tris-HCl, 150 mM
NaCl, 0.02% Tween 20) for 1 h at room temperature.
The membrane was incubated with mouse anti-His tag(C-terminal) primary antibody (Invitrogen, Carlsbad,
CA) for 1 h in 0.5% alkali-soluble casein-TBST (1:5,000).
After incubation with the primary antibody, the mem-
brane was washed three times with 0.5% alkali-soluble
casein-TBST for 5 min each time. The membrane was
then incubated with the secondary antibody (alkaline phos-
phatase conjugated anti-mouse) (Invitrogen, Carlsbad, CA)
for 1 h in 0.5% alkali-soluble casein-TBST (1:5000). The
membrane was washed in TBST three times for 5 min each
time, and then washed in TBS (without Tween 20) once for
5 min. The membrane was incubated for 3 min with the
substrate (Lumi-Phos WB; Fisher Scientific, Pittsburgh, PA)
at a volume of 0.125 mL per cm2 of membrane. LysA and
LysA2 were detected and visualized through chemilumines-
cence by exposing the membrane in Bio-Rad’s ChemiDoc
XRS + imaging system.
Statistical analyses
Pairwise comparisons and correlations were performed
using the statistical program JMP (version 9.0.0; SAS Insti-
tute Inc., Cary, NC). To measure significant differences,
analyses of variance (ANOVA) were performed. If a sig-
nificant difference (P < 0.05) was found with ANOVA,
then Student’s t-test was performed. The correlations were
estimated by the restricted maximum likelihood (REML)
method.
Results
Yeast-expressed endolysin purification and exolytic activity
His6-tagged LysA and LysA2 endolysins purified from
yeast migrated in SDS-PAGE analysis as discrete bands
to their predicted molecular masses of 37.9 kDa and
41.1 kDa, respectively (Figure 2a), suggesting that they
were not glycosylated during expression in yeast. A zymo-
gram gel was run in parallel with L. fermentum 0605-B44
cells embedded in the polyacrylamide gel matrix (Figure 2b).
A single translucent or dark band formed at the predicted
molecular mass for LysA and LysA2, confirming that
all lytic activity of each protein preparation resulted
from the full-length endolysin and not from any minor
contaminating bands (<25 kDa) that were co-purified
(Figure 2b).
The relative activities of E. coli and yeast-purified endo-
lysins were compared in turbidity reduction assays against
different Lactobacillus species. Yeast and E. coli-expressed
LysA and LysA2 effectively reduced the turbidity of log
phase cells of L. fermentum 0605-B44, L. brevis 0605-48,
and L. mucosae 0713-2 (Figure 3). In each instance,
LysA showed higher activity than LysA2 and endolysins
expressed from E. coli showed higher activity than
yeast-expressed endolysins (Figure 3). Endolysins were
most active against L. fermentum 0605-B44 and least active
against L. mucosae 0713–2 (Figure 3). Yeast-expressed
LysA lysed L. fermentum 0605-B44, L. brevis 0605-48, and
Figure 2 SDS-PAGE and zymogram analysis of purified yeast-expressed bacteriophage endolysins. (a) SDS-PAGE of yeast-expressed LysA
and LysA2 purified using Ni-NTA chromatography. Lane 1, 3 Precision Plus standard; Lane 2, 2.5 μg LysA (predicted MW= 37.9 kDa); Lane 4, 2.5 μg
LysA2 (predicted MW= 41.1 kDa). (b) Zymogram analysis with whole cells of L. fermentum 0605-B44 co-polymerized within the polyacrylamide gel.
Endolysin exolytic activity resulted in visible clearing (dark bands indicated by black triangles) of the cell substrate at the point of protein localization,
which corresponds with the predicted and observed molecular weights.
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194 mOD600/min/μM, which was 40%, 39%, and 29%
lower than the E. coli-expressed endolysins, respectively
(Figure 3). Yeast-expressed LysA2 lysed L. fermentum
0605-B44, L. brevis 0605-48, and L. mucosae 0713-2 at
a specific activity of 256, 119, and 116 mOD600/min/μM,
which was 17%, 19%, and 22% lower than the E. coli-
expressed endolysins, respectively (Figure 3).Figure 3 Turbidity reduction analysis of yeast (Y) and E. coli
(E)-expressed LysA and LysA2. Specific activities of 1 μM
endolysin were determined using mid-log phase cultures of L.
fermentum 0605-B44 (Lf), L. brevis 0605-48 (Lb), and L. mucosae
0713-2 (Lm). To control for the effect of autolysis, rates from
control samples (cells alone) were subtracted from the rates of
experimental samples. Bars not connected by the same letter are
significantly different (P < 0.05). Error bars represent the standard
error of the mean (n = 3).Expression of endolysins during fermentation reduces
Lactobacillus fermentum
The endolysins LysA and LysA2 were evaluated for their
ability to reduce the concentration of LAB in fermentations
that were experimentally infected with 5 log10 (CFU/mL)
L. fermentum 0605-B44 cells (Figure 4a-f). Samples were
taken at early time points (0, 0.5, 1.0, and 1.5 h) (Figure 4a,
c, e) and time points over three days (24, 48, and 72 h)
(Figure 4b,d,f) to enumerate bacterial concentration. No
bacterial colonies were observed in uninfected control fer-
mentations (data not shown). Fermentations containing
transformed yeast expressing (induced) LysA or LysA2
showed reduced bacterial concentrations at every time
point relative to those containing untransformed yeast
under induction conditions, transformed yeast under
non-induction conditions, and untransformed yeast under
non-induction conditions (Figure 4a-f). Reductions ranged
from 0.5 log10 (CFU/mL) (1.5 h, LysA) to 1.8 log10 (CFU/
mL) (24 h, LysA2) (Figure 4a,b).
For fermentations with yeast expressing LysA, the con-
centration of L. fermentum was significantly reduced at the
early time points (0 h to 1.5 h) relative to the induced fer-
mentations with untransformed yeast (P < 0.05) (Figure 4a).
This trend was somewhat reduced from 24 h to 72 h, with
fermentations containing yeast expressing LysA still
showing lower concentrations of L. fermentum, but the
differences were not significant (P > 0.05) (Figure 4b).
At 1.5 h, the average reduction for yeast expressing
LysA was 0.5 log10 (CFU/mL) and from 24 h to 72 h,
average reductions ranged from 0.5 log10 (CFU/mL)
(48 h) to 0.8 log10 (CFU/mL) (24 h) (Figure 4b). Fermenta-
tions containing yeast expressing LysA2 had significantly
lower bacterial concentrations than induced fermentations
Figure 4 Reduction of L. fermentum during fermentation of corn mash composed of 20% solids. Fermentations were prepared with
untransformed yeast (circles) or transformed yeast harboring LysA (triangles) or LysA2 (squares). The top panels (a, c, e) represent early time
points (0 h to 1.5 h) and the bottom panels (b, d, f) represent long-term (72 h) fermentations. (a-d) Induced fermentations were induced with
6.8 mL of 25% galactose (final conc. of 10%) and (e,f) non-induced fermentations were treated with 6.8 mL of DI water rather than galactose.
Samples of corn mash were taken at 0, 0.5, 1.0, 1.5, 24, 48, and 72 h to enumerate bacterial CFUs. (c,d) To prepare a yeast lysate containing LysA
or LysA2, 10% of the fermentation volume (2 mL) was removed at 0 h and 0.5 h and mechanically lysed (bead beating; BB) for five rounds of 30 s
followed by 30 s on ice and returned to the fermentation. Control samples included untransformed yeast under induced conditions, untransformed
yeast under induced conditions and BB, and untransformed yeast under non-induced conditions.
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(Figure 4a,b). At 1.5 h, fermentations with yeast express-
ing LysA2 resulted in an average reduction of 0.8 log10
(CFU/mL) (Figure 4a) and from 24 h to 72 h, average
reductions ranged from 0.9 log10 (CFU/mL) (72 h) to
1.8 log10 (CFU/mL) (24 h) (Figure 4b).
To augment the release of internally expressed endolysin
into the fermentation medium, 10% of the fermentation
volume was removed at 0 h and 0.5 h, mechanically lysed
in a bead beater, and immediately returned to the culture.
From 0.5 h to 72 h, the concentration of L. fermentum
was significantly lower (P < 0.05) in induced fermentations
containing transformed yeast expressing endolysins
that were mechanically lysed than in fermentations
containing untransformed yeast that were mechanically
lysed (Figure 4c,d). Applying yeast lysates containing
either LysA or LysA2 reduced L. fermentum levels in the
fermentations relative to the corresponding untransformed
yeast fermentations (Figure 4c,d) and demonstrated larger
reductions than internal expression alone (Figure 4c, d
versus 4a, b). Reductions ranged from 0.9 log10 (CFU/mL)
(0.5 h, LysA2) to 3.3 log10 (CFU/mL) (72 h, LysA)(Figure 4c,d). At 1.5 h, fermentations amended with yeast
lysate from transformed yeast (expressing LysA or LysA2)
resulted in average reductions of 0.9 log10 (CFU/mL)
and 0.8 log10 (CFU/mL), respectively (Figure 4c). From
24 h to 72 h, average reductions for LysA and LysA2
lysate-treated fermentations ranged from 2.6 log10 (CFU/
mL) (24 h) to 3.3 log10 (CFU/mL) (72 h) and 2.6 log10
(CFU/mL) (24 h) to 3.1 log10 (CFU/mL) (48 h), respect-
ively (Figure 4d).
For each time point, the effect of galactose and mechan-
ical lysis on L. fermentum concentrations was evaluated
with untransformed yeast fermentations. Galactose and
galactose plus mechanical lysis did result in minor reduc-
tions of L. fermentum concentrations (Figure 4a-d) when
compared to non-induced (no galactose) fermentations
containing untransformed yeast and non-induced fer-
mentations containing transformed yeast (Figure 4e-f );
however, this reduction was not statistically significant
(P > 0.05).
Western blot analysis of experimentally infected fermen-
tations at 72 h detected the presence of LysA and LysA2
in induced fermentations, and no protein was detected in
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induced (Figure 5).
Expression of endolysins reduces lactic acid and acetic
acid during fermentation
Experimentally infected fermentations expressing LysA
or LysA2 reduced lactic acid and acetic acid levels
(Table 1), and a correlation analysis revealed that the con-
centration of L. fermentum was positively correlated with
the concentration of lactic acid and acetic acid (r = 0.77,
P < 0.0001 and r = 0.83, P < 0.0001, respectively).
Among the infected-induced fermentations, those ex-
pressing LysA2 showed significantly reduced lactic acid at
48 h and 72 h and significantly reduced acetic acid levels
at 24 h, 48 h, and 72 h (P < 0.05) (Table 1). Lactic acid final
yields for induced fermentations with yeast expressing
LysA, LysA2, and fermentations with untransformed yeast
were 2.7, 1.7, and 3.4 mg/mL, respectively (Table 1).
Acetic acid final yields for induced fermentations with
yeast expressing LysA, LysA2, and fermentations with
untransformed yeast were 2.8, 1.9, and 3.0 mg/mL, re-
spectively (Table 1).
Induced fermentations that were treated with trans-
formed yeast lysate contained lactic acid and acetic
acid levels similar to those reported in the uninfected
control fermentations (lactic acid: 0.1 mg/mL and acetic
acid: ≤ 1.5 mg/mL; data not shown). The transformed
yeast lysate treated fermentations demonstrated sig-
nificant reductions in lactic and acetic acid at 48 h and
72 h (P < 0.05) (Table 1). Lactic acid final yields for
lysate-treated fermentations were 0.1, 0.1, and 3.7 mg/mL,
for LysA, LysA2, and untransformed yeast fermentations,Figure 5 Representative western blot of LysA and LysA2 from
experimentally infected fermentations containing transformed
yeast. Fermentation samples were collected at the end of
fermentation (72 h), and protein extractions were performed as
described. Fermentations containing transformed yeast that were
not induced served as a negative control. For analysis, 15 μL of each
extract were loaded onto a 12% polyacrylamide gel. Precision Plus
All Blue protein standard was used to determine relative protein
size. LysA and LysA2 bands were visualized at their predicted
molecular weight of 37.9 kDa and 41.1 kDa, respectively. Lane 1,
fermentation containing transformed yeast expressing LysA; Lane 2,
fermentation containing transformed yeast with LysA that was not
induced; Lane 3, fermentation containing transformed yeast
expressing LysA2; Lane 4, fermentation containing transformed yeast
with LysA2 that was not induced; Lane 5, fermentation containing
transformed yeast expressing LysA that was mechanically lysed; and
Lane 6, fermentation containing transformed yeast expressing LysA2
that was mechanically lysed.respectively (Table 1). Acetic acid final yields for lysate
treated fermentations were 1.3, 1.0, and 2.9 mg/mL, for
LysA, LysA2, and untransformed yeast fermentations, re-
spectively (Table 1).
Non-induced transformed yeast fermentations did not
reduce lactic acid or acetic acid levels relative to the corre-
sponding untransformed control (Table 1).
Ethanol concentrations in fermentations
Uninfected fermentations with untransformed yeast
had ethanol concentrations that were significantly higher
(P <0.05) than infected non-induced fermentations with
untransformed yeast at 48 h (41.6 mg/mL (data not
shown) versus 31.5 mg/mL (Table 1), respectively) and
72 h (55.3 mg/mL (data not shown) versus 35.6 mg/mL
(Table 1), respectively), indicating that L. fermentum con-
tamination caused a stuck fermentation to occur between
24 h and 48 h. Although experimentally infected fer-
mentations with yeast expressing LysA or LysA2 reduced
the concentration of L. fermentum and thus lactic and
acetic acid, ethanol levels were not significantly different
(P > 0.05) from the corresponding infected-induced
fermentations with untransformed yeast (Table 1). The
infected-induced fermentations containing transformed
yeast (expressing LysA or LysA2), including those treated
with yeast lysate, had final ethanol levels that ranged from
34.1 mg/mL to 46.2 mg/mL (Table 1), and the corre-
sponding infected-induced fermentations containing un-
transformed yeast had final ethanol levels of 41.5 mg/mL
and 37.4 mg/mL (lysate treated) (Table 1). The uninfected
fermentations containing untransformed yeast with and
without galactose had ethanol levels of 55.6 mg/mL and
55.3 mg/mL, respectively (data not shown), suggesting
that the ethanol yields were not altered by the addition of
galactose.
Discussion
Applying enzymes (for example, alpha-amylases) to fer-
mentations is standard procedure when preparing simul-
taneous saccharification and fermentation (SSF) cultures.
Therefore, a potential approach to reduce bacterial con-
tamination might be to add purified endolysins together
with hydrolytic enzymes at the start of fermentation.
The application of 1.0 mg purified LysA to 20 mL corn
mash fermentations did not reduce bacterial contamination
(results not shown), and preliminary work has suggested
that purified endolysins (λSA2 and LysA) are sequestered
by the corn mash solids (results not shown). Thus, the
amount of enzyme needed for this approach to be suc-
cessful is presently unknown and might be prohibitively
expensive. We predict that endolysin expression within
the fermentative yeast is much less costly than a special
formulation/additive to achieve a similar result. Thus, we
expressed the endolysins LysA and LysA2 in S. cerevisiae
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the concentration of L. fermentum and decrease the
production of lactic acid and acetic acid in experimen-
tally infected fermentations. Prior work by Roach et al.
[43] demonstrated the ability of four phage encoded
endolysins (LysA, LysA2, LysgaY, and λSa2), expressed
and purified from E. coli, to lyse different species of
Lactobacillus that were collected from fermentors at a
commercial dry grind ethanol facility. The endolysins
used in [43] and in this study were codon optimized for
their respective host system; however, differences in
protein production and processing between prokaryotic
and eukaryotic organisms [49] may yield enzymes with
different activities [50,51]. When expressed in yeast,
LysA and LysA2 were both soluble and active (Figure 2a,b).
When compared to LysA and LysA2 purified from E. coli
in simultaneous turbidity reduction assays against L. fer-
mentum, L. brevis, and L. mucosae (Figure 3), LysA was
more active than LysA2 as previously reported [43], and
the E. coli purified endolysins had higher specific activity
than those purified from yeast (Figure 3). The small differ-
ences in the specific activities observed between yeast and
E. coli purified proteins might be explained from the
minor co-purifying contaminant proteins observed in the
SDS-PAGE of the proteins purified from yeast (essentially
reducing the endolysin:total protein ratio) (Figure 2), but
which are absent in the E. coli purified proteins [43].
LysA and LysA2 were expressed in yeast without a
secretion signal but nevertheless were able to reduce
the L. fermentum concentration during fermentation
(Figure 4a,b). Although the mechanism for this result
is unclear, we speculate that these reductions may be a
result of natural yeast cell death and subsequent release of
the internally expressed endolysins. The median replica-
tive lifespan for the average laboratory yeast strain ranges
from 20 to 30 generations [52], and typically doubles after
90 min in rich media [53]. Cell death ensues via the
process of apoptosis, which occurs under three differ-
ent biological conditions [52]. During yeast cell lysis,
alterations occur in the cell wall structure [54,55],
resulting in the release of cellular components [56-58].
For example, during wine production, it is known that
internal S. cerevisiae components are released after cell
death and contribute to the sensory properties and bio-
logical stability of wine [56]. Furthermore, Hohenblum
et al. [59] reported that at the end of fermentation with
the yeast Pichia pastoris, 35% of the cells were dead
and contamination of the supernatant with host cell
proteins from lysed cells increased with increasing cell
death. Additional work will need to be conducted to
elucidate the exact mechanism(s) of L. fermentum re-
duction by yeast expressing endolysins (internally).
However, it is known that even a single endolysin mol-
ecule (for example, one escaping from the yeast cell)should be sufficient to cleave an adequate number of
bonds to lyse a bacterial cell [60].
To augment endolysin release via cell lysis, a yeast lys-
ate was prepared from 10% of the fermentation (contain-
ing endolysin expressing yeast) at 0 h and 0.5 h during
the assay and mechanically lysed. The yeast lysate was
immediately returned to the fermentation and caused a
significant reduction in the concentration of L. fermentum
that was maintained throughout the remainder of the ex-
periment (Figure 4c,d). The same effect was not observed
with mechanical lysis of fermentation samples that lacked
endolysin expressing yeast.
Although acetic acid and, to a lesser extent, lactic acid
were present in uninfected fermentations (data not shown)
[61], their levels were less than a third of those found in
experimentally infected fermentations at 72 h (Table 1).
When infected-induced fermentations containing untrans-
formed yeast were compared to infected non-induced
fermentations with untransformed yeast, we found that
galactose-containing fermentations significantly affected
lactic acid and acetic acid concentrations (Table 1). This
result coincided with a reduction in L. fermentum con-
centrations in the same flasks (Figure 4). The reduced
acid concentrations in these galactose-containing in-
fected fermentations might be due to the fact that many
microorganisms (such as Lactobacillus) prefer glucose
as the primary energy and carbon source and may be-
come stressed in the presence of uncommon sugars
[62,63]. However, while an effect was seen with galact-
ose, experimentally infected fermentations with yeast
expressing LysA or LysA2 showed reduced lactic acid and
acetic acid levels relative to the corresponding fermenta-
tions containing untransformed yeast under induction
conditions (Table 1). Alternatives to galactose induction
may include systems that require the addition of copper,
methionine, and beta-estradiol, which may avoid some
of the effects associated with the addition of galactose
[64-66].
A measurement of ethanol levels showed that the unin-
fected fermentations with untransformed yeast had ethanol
concentrations that were significantly higher than those of
infected non-induced fermentations with untransformed
yeast at 48 h and 72 h (P <0.05), indicating the negative
effect of L. fermentum on ethanol yields, and supporting
the use of our shake-flask model to mimic stuck fer-
mentation conditions experienced by industrial fermen-
tations. Although experimentally infected fermentations
with yeast expressing LysA or LysA2 reduced the con-
centration of L. fermentum and thus lactic and acetic
acid, ethanol levels were not significantly different from
the corresponding infected fermentations with untrans-
formed yeast under induction conditions (Table 1). The
fermentation efficiency of a given yeast strain is directly
related to its stress resistance or its ability to adjust
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able growth conditions) and mitigate stress [62]. Our
laboratory yeast strain BY4727 likely has a low stress resist-
ance relative to industrial yeast strains, which are developed
to be well adapted to fermentation conditions. For example,
fermentations with the high ethanol-producing yeast
strain NRRL Y-2034 had a final ethanol concentration of
112 mg/mL [4], and fermentations with the industry
yeast strain Ethanol Red reached a final ethanol concentra-
tion of over 140 mg/mL [47,67]. In contrast, the concentra-
tion of ethanol produced from uninfected fermentations
with our lab strain BY4727 was only about 55 mg/mL
(data not shown). Thus, if endolysins were expressed in
high ethanol-yielding and stress-tolerant yeast strains,
differences in ethanol levels may have been observed for
fermentations where bacterial contamination was re-
duced (fermentations with transformed yeast). We did
not observe any effects of endolysin expression on etha-
nol production in uninfected fermentations (data not
shown), but it is interesting that fermentations expressing
LysA consistently had higher ethanol levels than LysA2,
although not significantly, in experimentally infected fer-
mentations (Table 1).
Employing yeast to express antimicrobial genes repre-
sents a potentially cost-effective strategy to reduce LAB
contamination during batch fermentations. However, a
number of issues must be addressed before this process
is commercialized. First, yeast expressing endolysins in-
ternally to reduce bacterial contamination would likely
require high levels of protein production that is typically
observed using high copy plasmid-based expression sys-
tems. This would be suboptimal considering the high
likelihood of plasmid loss under non-selective fermenta-
tion conditions. Integrating the endolysin gene into the
yeast chromosome under the control of a promoter that
does not require an inducing agent would be favorable
for both batch and continuous fermentation systems and
would ensure gene passage to all progeny yeast, but the
transgene would need to be optimized for high level ex-
pression. Other strategies include secreting the endolysin
out of yeast [68] or displaying the endolysin on the sur-
face of the yeast cell wall [69]. Secretory expression of
heterologous proteins in yeast is complicated with
several existing technical problems, including protein
misfolding, degradation by host-specific proteases, and
low protein yields [68]. The secretion of heterologous
proteins from yeast has been most successful with pep-
tides, yet the secretion of large proteins has been less
predictable [65]. Second, the stability of endolysins in an
industrial environment and during industrial fermentation
processes together with the fate of endolysins during dis-
tillers dried grains with solubles (DDGS) production will
need to be examined. Initial bacterial loads have been
shown to be directly correlated with decreases in finalethanol yields [9]. Thus, the stability and activity of
endolysins will be most critical in the early stages of
the fermentation. As for the fate of the endolysins in
downstream processes, residual active enzymes would
likely be denatured by the heat of drying the DDGS,
which may occur at up to 232°C. Third, the use of
transgenic yeast for fuel ethanol production will need to
be accepted by policy makers and ethanol production fa-
cilities. The use of transgenic, commercially accepted yeast
strains to produce lysates containing endolysins for treat-
ing contaminated fermentations may avoid some of the
problems associated with the acceptance of using recom-
binant yeast during fermentation by ethanol facilities.
Conclusions
Bacteriophage endolysins are promising antimicrobial can-
didates for controlling LAB contamination in fuel ethanol
fermentations. LysA and LysA2 purified from yeast were
active against problematic lactobacilli collected from
fermentors at a commercial dry grind ethanol facility
including L. fermentum, L. brevis, and L. mucosae. When
using transformed yeast expressing either LysA or LysA2
in experimentally infected small-scale corn mash fermen-
tations, concentrations of L. fermentum 0605-B44 were
reduced up to 1.8 log10 (CFU/ml), and consequently lactic
acid and acetic acid levels were reduced up to 2.0 and 1.6-
fold, respectively. When transformed yeast lysates were
applied to experimentally infected fermentations, there
were significant (P < 0.05) reductions in the concentration
of L. fermentum (ranging from 0.9 log10 (CFU/mL) to 3.3
log10 (CFU/mL)), which were maintained throughout the
remainder of the 72-h fermentation period. Ethanol levels
achieved with our laboratory yeast strain were not com-
parable to ethanol levels normally achieved with industrial
strains, and were not significantly different from the
corresponding untransformed infected fermentations
under induction conditions. Thus, stuck fermentation
conditions in the mock fermentations were not mitigated.
To our knowledge, this is the first report demonstrating
the reduction of LAB contamination by employing yeast
expressing a bacteriophage lytic enzyme during fuel etha-
nol production, and provides a proof of principle and basis
for evaluating other antimicrobial peptides or enzymes for
their potential to reduce bacterial contamination during
biofuel production.
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